Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation

BACKGROUND: Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD) were limited by the lack of a reliable prognostic score to guide patient selection. Approximately 50% of hospitalised patients have a low mortality risk by DECAF, thus are potentially suitable. METHODS: In a non-infe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorax
Main Authors: Echevarria, Carlos, Gray, Joanne, Hartley, Tom, Steer, John, Miller, Jonathan, Simpson, A John, Gibson, G John, Bourke, Stephen C
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Chronic Obstructive Pulmonary Disease
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204956/
https://ncbi.nlm.nih.gov/pubmed/29680821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2017-211197
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados